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Abstract 
Introduction: Cancer is increasingly being viewed as a chronic illness requiring long-term 
management, and there is a growing need for evidence-based rehabilitation interventions for cancer 
survivors. Previous reviews have evaluated the benefits of exercise interventions for patients 
undergoing cancer treatment and long-term survivors, but none have investigated the role of exercise 
during cancer rehabilitation, the period immediately following cancer treatment completion. This 
systematic review summarises the literature on the health effects of exercise during cancer 
rehabilitation and evaluates the methodological rigour of studies in this area to date. 
Methods: Relevant studies were identified through a systematic search of PubMed and Embase to 
April 2009. Data on study design, recruitment strategy, participants, exercise intervention, adherence 
rates, and outcomes were extracted. Methodological rigour was assessed using a structured rating 
system. 
Results: Ten studies were included. Breast cancer patients were the predominate patient group 
represented. Most interventions were aerobic or resistance-training exercise programmes, and exercise 
type, frequency, duration and intensity varied across studies. Improvements in physical functioning, 
strength, physical activity levels, quality of life, fatigue, immune function, haemoglobin 
concentrations, potential markers of recurrence, and body composition were reported. However, all 
studies were limited by incomplete reporting and methodological limitations. 
Conclusions: Although the methodological limitations of studies in this new field must be 
acknowledged, initial evidence indicates that exercise is feasible and may provide physiological and 
psychological benefits for cancer survivors during the rehabilitation period. Future studies with 
rigorous study designs are now required to advance the field.  
 
 Key Words: Cancer; Exercise; Rehabilitation; Chemotherapy; Adherence. 
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Introduction 
The population of long-term cancer survivors continues to grow. In 2002 24.6 million people were 
living with cancer, worldwide.1 Improvements in treatment are, in part, responsible for the increased 
survival rates and life expectancies for cancer survivors. However, these treatments can be harmful, 
with many cancer survivors experiencing long-term negative physical and/or psychological effects 
from their disease or treatment. For this reason cancer is increasingly being viewed as a chronic 
illness requiring long-term management,2 and the need for evidence-based rehabilitation interventions 
for this population is growing. 
Exercise is increasingly becoming recognised as an important treatment for the recovery and 
rehabilitation of cancer survivors. The findings from previous reviews and meta-analyses suggest that 
exercise attenuates a range of physical and psychological complaints after cancer treatment. The 
benefits are thought to include reductions in fatigue and improvements in immune function, physical 
functioning, body composition, and quality of life (QoL).3-5 
Courneya and Friedenreich6 were the first to provide a framework for examining the short-
term and long-term benefits of exercise after cancer treatment. In their most recent physical activity  
and cancer control framework, they define the period following initial treatment, and ending with 
recurrence or death, as survivorship.7 They then separate survivorship into two time periods: the 
rehabilitation period, which immediately follows primary treatment, and the disease prevention/health 
promotion period, which describes longer-term survival. The duration of the rehabilitation period is 
highly variable but continues until any major loss of function is recovered.  Courneya and 
Friedenreich6 suggest that this time period can be defined approximately as the time from treatment 
completion to 3 to 6 months post-treatment. They argue that exercise and other types of physical 
activity are important throughout this period, as well as in the longer term survival period.  
Early reviews in this field summarised the evidence from all exercise interventions, regardless 
of whether patients were in the treatment, rehabilitation or survival period.  More recent reviews have 
separated the results of treatment and post-treatment interventions, but to date, no review has 
evaluated the effects of interventions offered during the rehabilitation period separately from the 
effects of those offered during the disease prevention/health promotion period. Therefore, little is 
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known about the specific benefits of exercise immediately following treatment, during which time the 
goal is to address the acute side-effects of treatment and facilitate a return to pre-treatment health.  
In their 2007 summary of the literature on physical activity and cancer control, Courneya and 
Friedenreich7 identified the rehabilitation period as a key focus for future research, particularly 
research to examine the feasibility and efficacy of exercise interventions. A number of factors explain 
this interest in offering exercise programmes during this period. First, during treatment, survivors 
typically experience a significant decline in their participation in exercise and other physical 
activities. Their levels of activity may not recover, even years after treatments have been completed.7, 
8 Considering the de-conditioned state of cancer survivors and the common presence of acute side 
effects at the completion of treatment, the possibilities for improvements in physical functioning, 
QoL, and immune function during the rehabilitation period are considerable.3 Second, cancer 
diagnosis has been described as a life changing event and completion of treatment can serve as a 
motivator to improve lifestyle risk factors, such as exercise and, more generally, physical activity 
participation. In a recent pilot study of a multi-strategy rehabilitation intervention for colorectal 
cancer survivors, cancer diagnosis was identified as a motivator for initiating the lifestyle changes 
promoted in the intervention.9 Participants identified 3 to 5 months post-treatment as their preferred 
time to start a rehabilitation programme because they felt that they were fit enough to make 
behavioural changes at that time, while not yet having lost their motivation to change. In another 
study, more than half the cancer survivors said they would prefer to begin an exercise programme 
immediately or soon after treatment, rather than during treatment.7 A potential reason for this 
preference could be that after treatment the time constraints imposed by medical appointments 
decrease. The third factor that could explain the interest in offering exercise during the rehabilitation 
period is the role of exercise programmes in providing continuing support to cancer survivors. Many 
cancer patients find this period challenging due to a sudden decline in both medical and social 
support: for example, they often report experiencing unanticipated fear and emptiness.10 Exercise 
programmes that offer social support to cancer survivors during this period could help them transition 
from the intense levels of support they receive during treatment.  
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What is known about the benefits of exercise during the rehabilitation period comes from the 
first generation of studies to test the efficacy and effectiveness of exercise programmes for cancer 
survivors in this period. It is now important to identify directions and challenges learned from these 
studies to prepare the next generation of studies in this field. Therefore, this study reviews the current 
literature on the role of exercise during the rehabilitation period. The purposes of this narrative 
systematic review are: (1) to summarise the literature on the health effects of exercise on cancer 
survivors in the rehabilitation period and (2) to evaluate the methodological rigour of studies that have 
examined these effects. The review will discuss: recruitment efforts, participants, interventions, 
adherence and compliance, analysis, and outcomes. 
 
Methods 
Search strategy and selection criteria 
Embase and PubMed were searched for articles prior to and including April 2009. Titles and abstracts 
were searched using the keywords cancer and exercise and clinical trials. The reference lists of 
located review articles on the topic and of articles describing original research were also checked. RS 
and KH developed the search strategy. RS then conducted the initial search, and in consultation with 
KH, determined eligibility of potential articles. WB confirmed the accuracy of the process used to 
conduct the search and determine eligibility.  
Studies were included if they were published in English and in a peer-reviewed journal. 
Studies that focused on the use of exercise to relieve or control lymphodema were excluded. The 
remaining inclusion criteria followed the PIOC (Population, Intervention, Outcomes, Comparison) 
framework.11 The population under study was defined as: cancer patients who had recently completed 
adjuvant chemotherapy and/or radiotherapy for any cancer and who had reported no plans for 
additional treatment (except hormone treatment for breast cancer). ‘Recently completed’ was initially 
conceptualized as having completed treatment no more than 6 months prior to enrolment. However, it 
became apparent early in the search process that this criterion was too narrow for such a new field of 
research. Therefore, this criterion was expanded to: having completed treatment no more than 12 
months prior to enrolment. This criterion could be met if: (1) the maximum time between treatment 
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completion and enrolment was ≤ 12 months for all participants in the study; (2) the mean time 
between treatment completion and enrolment plus two standard deviations was ≤ 12 months; or (3) 
the inclusion criteria stated the time between treatment completion and enrolment was ≤ 12 months. 
Studies were excluded if addition information provided about the recruitment process indicated that 
the study did not meet one of these criteria, even when the inclusion criterion was reported to be ≤ 12 
months since treatment completion. 
Interventions that met the criteria were aerobic and/or resistance training programmes, with or 
without range of motion or flexibility exercises; however, programmes that only included the latter 
exercises were excluded because these are not expected to lead to physiological improvements. Multi-
strategy programmes were also excluded unless one of the intervention groups was an exercise-only 
group. Studies describing the effects of a single bout of exercise were excluded as were studies that 
focused on the use of exercise to relieve or control lymphodema.. 
Outcomes that met the criteria were all possible health-related effects of cancer and ensuing 
treatments that would be evident during the rehabilitation period. These included disease- and 
treatment-related symptoms, QoL, fatigue, body composition, physical function/fitness and exercise 
behaviour.  
Studies that met the ‘comparison’ criterion of the PIOC inclusion criteria were single group 
pre-test post-test studies, controlled clinical trials, and randomised controlled trials.  It was important 
to include single-group studies as they are commonly used in newer research areas. 
 
Data extraction and quality assessment 
Descriptive characteristics of each study, including time between treatment completion and study 
enrolment, the study design, participant characteristics, and recruitment details, were extracted. Also 
extracted were descriptive data about the exercise programme, including the length of the programme; 
the duration, intensity and frequency of exercise sessions; and adherence or compliance with the 
programme. Last, the results of evaluating the effects of the intervention on health outcomes were 
extracted.  
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The methodological quality of the included studies was assessed using the method described 
by Stevinson et al.12 for a review of exercise and cancer throughout the cancer continuum. Four key 
features of methodological rigour were assessed: the use of randomisation for group allocation, the 
use of an unbiased randomisation method (e.g. randomisation took place at a remote site or involved 
drawing sealed sequentially numbered envelopes), the blinding of data collectors from group 
allocation, and the use of intention-to-treat analysis.  
 
Results 
The database searches identified 668 references. Review of their titles and abstracts revealed that 538 
did not meet the inclusion criteria. The full texts of the remaining 130 articles were retrieved for more 
detailed evaluation. Of these, 117 articles were excluded and 13 were included in this review, based 
on the study criteria (Fig. 1). 
INSERT FIGURE 1 ABOUT HERE 
Excluded studies 
Of the 117 excluded studies, 63 were excluded because they were not exercise interventions post-
treatment. Fifty-four of these described interventions for patients during cancer treatment, or for a mix 
of patients, some in treatment and some in the survival period. Another nine did not describe the 
evaluation of an exercise intervention (e.g. letters to the editor or protocol papers). The remaining 67 
articles described exercise interventions post-treatment. Fifty-four of these were excluded because 
they did not describe interventions for the rehabilitation period. Two of these 54 were excluded 
because the primary focus of the interventions was range of motion exercises for lymphodema, 
following breast cancer treatment,13, 14 and another was excluded because the intervention was multi-
strategy.15 For another 25 of these 54 excluded studies, the article did not report the time between 
treatment completion and study enrolment in a way that met the inclusion criteria: 15 of these only 
reported time between diagnosis and study enrolment; another six defined participants by time since 
surgery; and the remaining four reported medians or minimum time between treatment completion 
and study enrolment. Another 26 of these 54 excluded studies included participants who were >12 
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months post-treatment. Nineteen of these studies included cancer survivors who were ≤5 years post-
treatment, and seven included cancer survivors who were >5 years and ≤21 years post-treatment.  
 
Included studies 
The 13 articles16-28 that met the inclusion criteria describe 10 post-treatment intervention studies 
(Hayes et al.21-24 reported their study findings in four articles). Characteristics of the studies and their 
findings are reported in Table 1. Information on the methodological quality of each study and 
compliance/adherence rates within studies are reported in Table 2.  
INSERT TABLE 1 ABOUT HERE 
Time since treatment 
As required by the inclusion criteria, all the included studies reported the time between treatment 
completion and study enrolment. However, only four studies reported the range of time between 
treatment completion and study enrolment,19, 21, 27, 28 which allowed for accurate estimation of the 
maximum time between treatment completion and study enrolment. One other study reported the 
mean and standard deviation,16 with the remaining five studies only reporting the inclusion criterion 
for the duration of time since treatment completion.  
Even within the tight inclusion criteria, a range of time periods was represented. Time since 
diagnosis ranged from <1 month to <12 months. Three studies included participants who were <1 
month post-treatment.21, 25, 26 Three others included participants who were <6 months post-treatment,16, 
17, 19 and an additional three included participants who were <12 months post-treatment.18, 27, 28 The 
remaining study20 reported the inclusion of participants who were recruited ‘within weeks of 
completing treatment’. 
 
Study designs 
Four of the 10 included studies were randomised controlled trials with participants randomised to an 
exercise intervention group or a non-exercise control group.16-18, 26 Three other studies were controlled 
clinical trials, but used non-randomised group allocation methods.19, 21, 25 Allocation decisions were 
based instead on proximity to exercise facility,19, 25 matching characteristics21 or participant 
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preference.19  Two studies allocated participants to either a moderate-intensity or high-intensity 
exercise group (i.e. no control group),27, 28 and one used a single group design.20 
 
Sample size and recruitment  
Power calculations were only reported for four studies,16, 21, 26, 27 all of which recruited the intended 
number of participants (range of 12-111 participants).  In the other studies sample sizes ranged from 
23-74, with a median of 42, but no information on sample size calculations was provided.  Several 
studies noted the difficulties of recruiting the required number of participants.  For example, Hayes et 
al.21 reported ‘slow recruitment and low numbers’ in a population of high-dose chemotherapy 
survivors and discussed the subsequent abandonment of the randomisation process. Matthews et al.18 
noted that recruitment was impacted at one site by stringent inclusion criteria. After recruiting only 
8% of eligible patients, they changed the inclusion criteria for recruitment at a second site, which 
improved the recruitment rate to 20% of eligible patients at that second site.  In contrast, a high 
recruitment rate of 71% was reported by Thorsen et al.,16 who recruited 111 participants. Few studies 
mentioned how they recruited their participants.  One study reported recruiting a consecutive series of 
patients;25 one reported recruiting a convenience sample;20 and one reported recruiting through 
'physicians and advertisements'.19 Recruitment strategies were not reported for the other studies.   
 
Participants  
Studies included survivors of a variety of cancers, with most survivors having a breast cancer 
diagnosis. Four studies included breast cancer survivors only.17-20 Another four included survivors of a 
range of cancer types (e.g. lymphomas, gynaecological, breast and testicular cancers);16, 21, 25, 26 
however, three of these included primarily breast cancer survivors.16, 25, 26 The remaining two studies 
recruited colorectal cancer survivors.27, 28 
The age of participants ranged from 16-71 years, with most studies including a wide range of 
ages. Except for the four studies that included only female breast cancer survivors, the studies 
recruited men and women. 
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Control groups 
Information on control group instructions was reported for four of the seven controlled trials. For two 
studies, control group participants were told to maintain current levels of physical activity for the 
duration of the study,16, 17 and for another study, they were offered a variation of the intervention after 
the study ended.18 In a fourth study the control group took part in a stretching programme that 
provided contact time with a trainer equal to the time given to the exercise group participants, but the 
contact was not intended to lead to improvements in physiological variables other than flexibility.21 
Three of the 10 studies had no control group.20, 27, 28 
 
Interventions 
The exercise interventions varied across the 10 included studies. The intervention period ranged from 
2 weeks (n = 326-28) to 6 months (n = 120). Eight interventions were supervised exercise 
programmes.17-28 One of these also encouraged participants to exercise at home.17 The two remaining 
interventions were home-based, un-supervised exercise programmes.16, 18 One of these employed 
exercise physiologists to prescribe individually-tailored exercise programmes.16 The investigators of 
the other study did not specify the qualifications of the person employed to deliver in-person and 
phone exercise counselling.18  
The frequency, type, intensity and duration of the exercise interventions and the speed and 
manner in which the prescriptions were progressed also differed among studies. Exercise frequency 
ranged from daily (n = 425-28) to a minimum of two sessions per week (n = 216, 20). A range of 3 to 5 
sessions per week was reported for the remaining four studies, with more sessions being required later 
in the study.  
Six studies incorporated only aerobic exercise,17, 18, 25-28 and four incorporated aerobic and 
resistance exercises. Most studies prescribed cycling or walking ergometers for the aerobic 
component of the exercise sessions (n = 719-21, 25-28). Two, however, incorporated a range of 
modalities, including walking, cycling, ‘aerobics’ exercise (e.g. stepping classes), ball games and 
swimming,16, 17 and one study prescribed walking only.18 Studies incorporating resistance training 
prescribed either exercises using machines20, 21 or resistance bands.19 In one study participants 
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primarily engaged in aerobic exercise but could also choose to include resistance exercises in 
whatever way they chose.16 Flexibility exercises were included as part of the warm-up or cool down 
in two studies.19, 20  
The comparison of exercise intensities is complicated by the variety of methods used to 
measure intensity. One study used a treadmill speed corresponding to a lactate concentration of 3±0.5 
mmol/L in capillary blood (which corresponds to 90±5% of maximal heart rate).25  Six studies 
prescribed intensity based on maximum heart rate, assessed with a maximal exercise test,19, 21 as heart 
rate reserve (using the formula [(220-age)-resting heart rate] x percent of exercise intensity + resting 
heart rate20, 26), or as maximum power output.27, 28 The remaining three studies prescribed an intensity 
of 6 to 20 on the Borg rating of perceived exertion (RPE) scale.16-18 Two of these studies also used 
heart rate monitors to check intensity.16, 17 Actual intensities of the exercise prescribed across all the 
studies ranged from light to moderately-light intensity, described as an RPE of 11 to 13 on the Borg 
scale,18 to a moderate to high intensity (described as 70-90% of maximum heart rate 21, 25).   
Duration of exercise sessions ranged from 30 min (n = 316, 25, 26) to 90 min (n = 119). In the 
seven studies lasting longer than 2 weeks,16-21, 25 the exercise prescriptions generally increased in 
intensity and/or duration gradually over the intervention period. For most of these studies, however, 
detailed descriptions about the progression in prescriptions were lacking.  
 
Adherence and compliance 
Adherence to the exercise protocol was reported fairly consistently, with only three of the 10 studies25, 
27, 28 neglecting to discuss exercise adherence. Across the seven studies that reported adherence, rates 
were high (approximately 80-90%).One study reported an adherence rate of approximately 90%, but 
did not define how this was calculated.20 For the other six studies, adherence was defined in one of 
two ways: the percentage of prescribed exercise sessions completed or the number or percentage of 
participants who completed the prescribed number of sessions per week. Adherence to supervised 
exercise sessions was assessed by attendance logs, and adherence to unsupervised sessions was self-
reported.  
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Three studies reported adherence as the number or percentage of participants who completed 
the prescribed number of weekly sessions.16, 19, 21 In a 14-week intervention trial of unsupervised and 
supervised exercise, 97% of mixed cancer survivors (57 of 59) self-reported that they had met the goal 
of two sessions per week.16 In a study of breast cancer survivors, 82% of participants (23 of 28) 
completed the goal of three supervised sessions per week over the 12-week intervention.19 Last, 67% 
of mixed cancer survivors enrolled in a 12- week supervised exercise programme after completing 
high-dose chemotherapy (4 of 6), completed all sessions, while 33% (2 of 6) each missed three 
sessions.21 
Three studies reported adherence as the number or percentage of prescribed sessions that were 
completed.17, 18, 26 In a study of mixed cancer survivors who were in hospital after completing high-
dose chemotherapy, Dimeo et al.26 reported that participants attended daily supervised exercise 
sessions on 82% of the days they spent in hospital (approximately 2 weeks). Breast cancer survivors 
enrolled in a 12-week intervention completed 78% of weekly supervised sessions and a mean of 2.1 
unsupervised home-based sessions (minimum prescribed = 2 sessions).17 In another 12-week 
intervention, breast cancer survivors reported that they completed 94% of unsupervised walking 
sessions18 This was confirmed objectively with a subsample of participants (23 of 36),who wore an 
Actigraph accelerometer during the sixth and twelfth weeks of the intervention. At the 12-week 
follow-up, walking frequency and duration, measured with the accelerometer, was strongly correlated 
with self-reported walking (rho=0.65, p<0.01). The investigators also reported a downward trend in 
self-reported walking adherence over the follow up period (adherence= 108% [walking more than 
prescribed] at month 1; 88% at month 2; 76% at month 3).    
Compliance to the exercise intervention protocol was not reported by any study, and therefore 
it is not possible to report how well participants followed the exercise prescriptions. 
 
Outcomes 
Physical Function 
Six studies reported improvements in physical function,16, 17, 19, 20, 22, 25 and one study reported reduced 
loss of physical function.26 In a population of high-dose chemotherapy survivors, patients allocated to 
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6 weeks of daily exercise had significantly greater improvements in maximum performance 
(measured in METs) on a treadmill test than did patients in the control group.25 The clinical 
significance of this is highlighted by the fact that at follow up, only 6% of the exercise group failed to 
exercise at a level sufficient to perform activities of daily living, compared with 25% of the control 
group. A similar population of high-dose chemotherapy survivors also showed a significant 
improvement in maximal performance (measured as VO2 max), in addition to improvements in upper 
and lower body strength, after 3 months of aerobic and resistance training.22 No improvements were 
seen in the control group. Improvements in maximal performance were also reported in populations of 
mixed cancer survivors16 and breast cancer survivors,19, 20 after combined aerobic and resistance 
training interventions lasting 12 weeks to 6 months. In one of these studies, the combined aerobic and 
resistance training intervention also led to improved upper and lower body strength.19 In the other 
study of breast cancer survivors, which was a single group trial, other improvements reported were 
increased time to exhaustion during a fitness test, increased percentage of age-predicted forced vital 
capacity, and decreased resting heart rate.20 In another study of breast cancer survivors17 greater 
improvements in dynamic agility and peak jumping power were seen in the exercise group than in the 
control group, although no significant between-group differences were found for muscle strength or 
timed 2-km walk distance, after a 12-week aerobic and resistance training intervention. Other 
outcomes reported by the included studies were an increase in total energy expenditure in the exercise 
group24 (not assessed in the control group) in a mixed cancer sample and greater increases in walking 
for exercise over 12 weeks in the exercise group than in the control group in a breast cancer sample.18 
 
Fatigue and Quality of Life 
Fatigue was measured in three studies, using a patient interview,25 the fatigue subscale of the EORTC-
QLQ QOL questionnaire16 or the Piper Fatigue Scale.20 In a study of patients who had received high-
dose chemotherapy, no patients who were allocated to 6 weeks of daily exercise reported fatigue in 
patient interviews, compared with 25% of patients allocated to the control group.25 Conversely, in a 
breast cancer population, scores on the EORTC fatigue scale improved more in the control group than 
in the intervention group over 14 weeks.16 Substantial participation in exercise over the intervention 
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period was noted in the control group; however, no association was found between changes in fatigue 
and improvements in physical fitness for this sample. The authors hypothesised that the fatigue scale 
may have been sensitive to acute changes in fatigue rather than long-term chronic fatigue, and, 
therefore, the scale may not have been appropriate as an outcome measure. In a different population 
of breast cancer survivors, Hsieh et al.20 reported significant improvements in behavioural, affective, 
sensory, cognitive, mood and total fatigue, as measured with the Piper Fatigue Scale, after 6 months 
of aerobic and resistance training. No changes in mental distress and emotional function were found.  
QoL was measured in only one study.23 Using the Cancer Rehabilitation Evaluation System to 
assess QoL, the investigators reported significantly greater improvements in global and all domains of 
QoL (physical, psychosocial, medical interaction, marital and sexual) in cancer survivors who 
completed a 3-month aerobic and resistance training intervention, compared with those in a control 
group.  
 
Haematological and Immunological Outcomes 
A variety of markers has been measured to evaluate the impact of exercise on immune function and 
haematological outcomes related to recovery and recurrence. Three studies investigated 
immunological and haematological markers in cancer survivors following high-dose chemotherapy21, 
25, 26 and one in a population of breast cancer survivors.19 In cancer survivors who had received high-
dose chemotherapy, Hayes et al.21 found no change in the speed of immune cell recovery following a 
12-week exercise intervention; however, the exercise programme did not negatively impact immune 
function either. Improvements identified in a similar population after either a 2-week or a 6-week 
exercise intervention included significantly greater decreases in neutropenia and thrombopenia in the 
exercise group than in the control group26 and significantly higher haemoglobin concentrations in the 
exercise group than in the control group.25 In the study of breast cancer survivors the exercise group 
showed greater lymphocyte activation after a 6-month exercise intervention than did the control 
group, which may indicate improved immune function.19  
Two other studies examined the effect of low- and high-intensity exercise on potential 
markers of recurrence.27, 28  In the first study, only the higher-intensity exercise group experienced a 
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shift to a more pro-inflammatory and less anti-inflammatory immune state (which is hypothesised to 
decrease infection and cancer recurrence rates) after 2 weeks of intervention.28  In the second study, 
there was a decrease in oxidative DNA damage (a biomarker of cancer recurrence) in the lower-
intensity exercise group and an increase in the higher-intensity exercise group.27 The clinical 
significance of these changes is not known for either outcome. 
 
Body Composition 
Two studies reported body composition as an outcome.18, 24 In one study24 an increase in fat-free mass 
was associated with a decrease in percentage of body fat, in a sample of cancer survivors who 
completed a 12-week moderate- to high-intensity aerobic and resistance training intervention after 
completing high-dose chemotherapy. In contrast, no significant changes in body composition or 
weight were found for breast cancer survivors who followed a 12-week home-based, unsupervised 
light- to moderate-intensity walking intervention.18 However, there was a tendency towards a decrease 
in fat mass and an increase in fat-free mass in the exercise group (and vice versa in the control group) 
between baseline and intervention completion. 
 
Methodological evaluation of the studies 
The methodological features of the studies are summarised in Table 2. None of the studies met all 
four criteria used to assess quality in this review.  Using the information reported, three of the 10 
studies met two criteria;16-18 three met one criterion;19, 26, 28 and four met none of the criteria.20, 21, 25, 27 
Four studies used randomisation to allocate participants to groups,16-18, 26 and of these, only Thorsen et 
al.16 reported an unbiased randomisation process, using computerised random assignment from an 
external site. Four studies analysed data on an intention-to-treat basis.17-19, 28 In another five articles, 
the analyses were described as intention-to-treat; however, data from some participants were not 
included in the analyses.16, 21, 25-27 For all studies information about the flow of participants through the 
study was provided, and all reported the numbers of participants who dropped out or were lost to 
follow-up. Blinding of data collectors to group allocation was not reported by any study, and thus this 
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criterion could not be adequately assessed. Six studies, however, included haematological or 
immunological outcomes, which were likely to have been assessed by blinded assessors.19, 21, 25-28 
INSERT TABLE 2 ABOUT HERE 
 
Discussion 
This systematic review summarizes the major results and evaluates the methodological quality of 
exercise interventions for cancer survivors during the rehabilitation period. To our knowledge this is 
the first review to focus on this time period, which commences immediately after primary cancer 
treatment is completed. Only 10 studies (described in 13 articles16-28) were located for inclusion in this 
review, which illustrates the ‘early’ nature of this work. Although variations in participants, study 
designs and interventions among the studies do not allow for a synthesis of their data, the findings 
from this review suggest that exercise can provide a variety of benefits for cancer survivors during the 
rehabilitation period. These include positive impacts on physical functioning, strength, physical 
activity levels, QoL, fatigue, immune function, haemoglobin concentrations, potential markers of 
recurrence, and body composition. 
While most researchers reported their outcomes reasonably well, methodological details were 
lacking for most studies. Study characteristics that were not described well included: the timing 
between treatment completion and study enrolment, the recruitment process (including what strategies 
were or were not successful), and adherence to the exercise programme. Compliance with the exercise 
prescription or study protocol was not discussed in any study. These omissions do not allow for a 
comprehensive assessment of study quality, generalizability of findings, or potential sources of bias, 
all of which would be valuable to researchers who are developing future intervention studies for 
cancer survivors post-treatment. 
Most studies also suffered from methodological limitations. No study reported whether data 
collectors were blinded from group allocations, and none met all the three remaining criteria for 
methodological rigour developed by Stevinson et al.12 (randomisation of group allocations, unbiased 
randomisation process, and the use of intention-to-treat analysis). The highest quality score was 2 of 4 
criteria, which was achieved by three studies.16-18 All three were randomised controlled trials. Only 
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one of these reported power calculations, and it was the largest included study (n = 111).16 Four 
studies did not meet any criterion, and none of these were randomised controlled trials.20, 21, 25, 27  
 After examining the quality ratings and other study characteristics (e.g. study design, sample 
size, type of exercise intervention, reporting of power calculations), it became apparent that no high 
quality studies of exercise interventions in the rehabilitation period have been published to date. This 
reflects not only the lack of information reported for each study but also the newness of this field  As 
the research expands in this area, it is expected that the methodological quality of the studies will 
improve, as it has for studies of exercise interventions for patients during breast cancer treatment. To 
improve the quality of research in this area, researchers should address issues of methodological 
quality, in addition to ensuring all factors are reported accurately. 
An additional finding was that studies varied considerably in the exercise prescribed, which 
makes it difficult to recommend a specific exercise protocol for cancer survivors in the rehabilitation 
period. Nonetheless, all the prescribed exercise interventions were deemed safe and feasible for the 
targeted populations. Additionally, adherence rates (reported by 7 of 10 studies) were high, suggesting 
that cancer survivors who participate in exercise studies are highly motivated, regardless of the 
exercise prescription. It should be noted, however, that none of the studies reported participant 
preferences for frequency, type, intensity or duration of exercise sessions. Without evidence about 
these preferences or the optimal exercise prescription for health benefits, future researchers should 
continue to prescribe exercise as appropriate for the intended study outcomes (e.g. increased fitness, 
decreased fatigue). Exercise prescriptions should take into consideration (1) general population 
prescription guidelines (e.g. American College of Sports Medicine29); (2) successful protocols from 
previous studies with cancer survivors (such as those included in this review); and (3) the 
requirements of the specific cancer survivor population (e.g. weight bearing exercise for survivors of 
treatments that decrease bone strength). 
Two further limitations of the studies in this review should be noted. Although it was outside 
the scope of this review to explore these in detail, they are important for evaluating the quality of the 
literature in this field. First, as identified in previous reviews of exercise and cancer patients12, 30 most 
of the studies had numerous outcomes, more than the number assessed in the current review. Second, 
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the studies tended to report only positive findings, arbitrarily defined as those having a p-value of less 
than 0.05. The biases in making multiple statistical comparisons and reporting only positive findings 
must be acknowledged.  
 
Limitations of the review 
Although a comprehensive literature search was performed, it is possible that eligible studies were 
missed. Even if every published paper had been included, there could still have been bias arising from 
the fact that many of the published studies assessed multiple outcomes but reported only the positive 
findings.  In contrast, reliance on published studies probably resulted in the inclusion of the most 
rigorous studies, which were likely to have their findings reported no matter the outcome. Due to the 
small number of studies and the heterogeneity in populations, exercise programmes, outcomes and 
follow-up periods, a meta-analysis, or a discussion of trends in outcomes, was not deemed feasible at 
this time. 
 
Future directions 
To advance the field, researchers evaluating exercise interventions during the rehabilitation period are 
encouraged to:  
‐ Develop a consistent timeframe to define the rehabilitation period 
‐ Evaluate changes in outcomes most relevant to the rehabilitation period (e.g. physical 
functioning, QoL, immune/haematological, markers of recurrence, participants feelings of 
support, PA levels) 
‐ Identify appropriate measures of these outcomes for the target population, and standardise 
measures to allow for cross-study comparisons 
‐ Undertake further feasibility studies in understudied populations to ensure piloting of 
interventions and collection of baseline data for future sample size calculations, prior to 
implementing large scale studies 
‐ Avoid methodological limitations in large-scale studies for which sufficient feasibility data 
exists (e.g. breast cancer) by using: 
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o Randomised group allocation 
o Unbiased randomisation method for group allocation (e.g. at a remote site or by  
drawing sealed sequentially numbered envelopes) 
o Data collectors blinded to group allocation 
o Intention-to-treat analysis 
In reporting evaluations of exercise interventions for cancer survivors during the rehabilitation period, 
researchers are encouraged to report:  
‐ Time (the range of weeks or months) between cancer treatment completion and study 
enrolment 
‐ Adherence with the intervention protocol and compliance with the exercise prescription 
‐ Power calculations 
‐ Findings from all analyses conducted, including null findings 
‐ Effect sizes and comparisons with pre-determined clinically significant effect sizes 
‐ Successes and failures with recruitment and intervention implementation  
 
Conclusion 
Few intervention studies have been conducted with cancer survivors in the rehabilitation period. As 
might be expected of research in an emerging field, methodological limitations are evident in studies 
in this field. These make it difficult to draw firm conclusions about the efficacy or effectiveness of 
exercise interventions for these cancer survivors. Acknowledging these limitations, the initial 
evidence indicates that exercise programmes are feasible and may provide physiological and 
psychological benefits for cancer survivors during the rehabilitation period. Future studies with 
rigorous study designs are now required to advance the field. 
 
Conflict of interest statement 
None of the authors have any financial and personal relationships with other people or organisations 
that could inappropriately influence this work. 
 
21 
 
Acknowledgements 
RS is supported by a Postgraduate Research Scholarship from The University of Queensland. RS and 
KH are supported by a NHMRC program grant (grant no. 301200) in physical activity and health at 
The University of Queensland, School of Human Movement Studies. Funding sources had no 
involvement in the study design, data collection, analysis and interpretation of the data, writing of the 
manuscript, or the decision to submit the manuscript for publication. 
22 
 
REFERENCES 
1. World Health Organization, International Union Against Cancer. Global action against 
cancer - updated version.  2005  [cited 2009 September]; Available from: 
http://www.who.int/cancer/media/GlobalActionCancerEnglfull.pdf. 
2. Pinto BM, Trunzo JJ. Health behaviors during and after a cancer diagnosis. Cancer 2005; 
104(11 Suppl): 2614-23. 
3. Galvao DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin 
Oncol 2005; 23(4): 899-909. 
4. Kirshbaum MN. A review of the benefits of whole body exercise during and after treatment 
for breast cancer. J Clin Nurs 2007; 16(1): 104-21. 
5. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in 
cancer patients during and after medical treatment: A systematic review of randomized and 
controlled clinical trials. J Clin Oncol 2005; 23(16): 3830-42. 
6. Courneya KS, Friedenreich CM. Framework peace: An organizational model for examining 
physical exercise across the cancer experience. Ann Behav Med 2001; 23(4): 263-72. 
7. Courneya KS, Friedenreich CM. Physical activity and cancer control. Semin Oncol Nurs 
2007; 23(4): 242-52. 
8. Hawkes AL, Lynch BM, Youlden DR, Owen N, Aitken JF. Health behaviors of australian 
colorectal cancer survivors, compared with noncancer population controls. Support Care 
Cancer 2008; 16(10): 1097-104. 
9. Anderson AS, Caswell S, Wells M, Steele RJ, Macaskill S. "It makes you feel so full of life" 
Livewell, a feasibility study of a personalised lifestyle programme for colorectal cancer 
survivors. Support Care Cancer 2009. 
10. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006; 
24(32): 5132-7. 
11. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: A 
key to evidence-based decisions. ACP J Club 1995; 123(3): A12-3. 
12. Stevinson C, Lawlor DA, Fox KR. Exercise interventions for cancer patients: Systematic 
review of controlled trials. Cancer Causes Control 2004; 15(10): 1035-56. 
13. Kilgour RD, Jones DH, Keyserlingk JR. Effectiveness of a self-administered, home-based 
exercise rehabilitation program for women following a modified radical mastectomy and 
axillary node dissection: A preliminary study. Breast Cancer Res Treat 2008; 109(2): 285-95. 
14. Pickett M, Mock V, Ropka ME, Cameron L, Coleman M, Podewils L. Adherence to 
moderate-intensity exercise during breast cancer therapy. Cancer Pract 2002; 10(6): 284-92. 
15. Berglund G, Bolund C, Gustavsson UL, Sjoden PO. Starting again--a comparison study of a 
group rehabilitation program for cancer patients. Acta Oncol 1993; 32(1): 15-21. 
16. Thorsen L, Nystad W, Stigum H, et al. Cardiorespiratory fitness in relation to self-reported 
physical function in cancer patients after chemotherapy. J Sports Med Phys Fitness 2006; 
46(1): 122-7. 
17. Nikander R, Sievanen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, Saarto T. Effect of a 
vigorous aerobic regimen on physical performance in breast cancer patients - a randomized 
controlled pilot trial. Acta Oncol 2007; 46(2): 181-6. 
18. Matthews CE, Wilcox S, Hanby CL, et al. Evaluation of a 12-week home-based walking 
intervention for breast cancer survivors. Support Care Cancer 2006. 
19. Hutnick NA, Williams NI, Kraemer WJ, et al. Exercise and lymphocyte activation following 
chemotherapy for breast cancer. Med Sci Sports Exerc 2005; 37(11): 1827-35. 
20. Hsieh CC, Sprod LK, Hydock DS, Carter SD, Hayward R, Schneider CM. Effects of a 
supervised exercise intervention on recovery from treatment regimens in breast cancer 
survivors. Oncol Nurs Forum 2008; 35(6): 909-15. 
21. Hayes SC, Rowbottom D, Davies PS, Parker TW, Bashford J. Immunological changes after 
cancer treatment and participation in an exercise program. Med Sci Sports Exerc 2003; 35(1): 
2-9. 
23 
 
22. Hayes SC, Davies PS, Parker TW, Bashford J, Green A. Role of a mixed type, moderate 
intensity exercise programme after peripheral blood stem cell transplantation. Br J Sports 
Med 2004; 38(3): 304-9; discussion 9. 
23. Hayes S, Davies PS, Parker T, Bashford J, Newman B. Quality of life changes following 
peripheral blood stem cell transplantation and participation in a mixed-type, moderate-
intensity, exercise program. Bone Marrow Transplant 2004; 33(5): 553-8. 
24. Hayes S, Davies PS, Parker T, Bashford J. Total energy expenditure and body composition 
changes following peripheral blood stem cell transplantation and participation in an exercise 
programme. Bone Marrow Transplant 2003; 31(5): 331-8. 
25. Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the 
rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem 
cell transplantation. Cancer 1997; 79(9): 1717-22. 
26. Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J. Effects of aerobic exercise on the 
physical performance and incidence of treatment-related complications after high-dose 
chemotherapy. Blood 1997; 90(9): 3390-4. 
27. Allgayer H, Owen RW, Nair J, et al. Short-term moderate exercise programs reduce oxidative 
DNA damage as determined by high-performance liquid chromatography-electrospray 
ionization-mass spectrometry in patients with colorectal carcinoma following primary 
treatment. Scand J Gastroenterol 2008; 43(8): 971-8. 
28. Allgayer H, Nicolaus S, Schreiber S. Decreased interleukin-1 receptor antagonist response 
following moderate exercise in patients with colorectal carcinoma after primary treatment. 
Cancer Detect Prev 2004; 28(3): 208-13. 
29. American College of Sports Medicine., Whaley MH, Brubaker PH, Otto RM, Armstrong LE, 
American College of Sports Medicine. Acsm's guidelines for exercise testing and 
prescription. 7th ed, Baltimore: Lippincott Williams & Wilkins; 2006. 
30. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane 
Database Syst Rev 2008(2): CD006145. 
 
 
24 
 
Table 1. Characteristics and results of studies that evaluated the effects of exercise on cancer survivors during the rehabilitation period (sorted by ‘months since treatment’). 
Study Months 
since 
treatmenta 
(criteria) 
Type 
of 
study 
No. of 
Patients 
Sex Age 
(years) 
Types of 
Cancer 
Duration 
(wks of 
exercise) 
Exercise Programme Intensity Frequency Results 
 
Dimeo et al.26 
 
≤.5 
(criteria) 
 
 
RCT 
 
Ex: 33 
C: 37 
 
M, W 
 
39-40 
(mean) 
 
Mixed - 
mainly breast 
cancer 
following 
HDC & 
PBST 
 
~2 
 
Cardiovascular cycling 
30 minutes (intervals) 
(15 x [1 minutes cycling 
at intensity + 1 minutes 
recovery]) 
 
(supervised) 
 
50% HRR 
 
Daily while 
in hospital  
 
- ↓drop in maximal performance 
- ↓neutropenia & thrombopenia duration 
- ↓symptoms 
- ↓duration of hospitalisation 
Dimeo et al.25 ≤.5 
(criteria) 
CCT Ex: 16 
C: 16 
M, W 39-42 
(mean) 
Mixed – 
mainly breast 
cancer and 
non-
Hodgkin’s 
lymphoma 
following 
HDC & 
PBST 
6 5 x 3min – 1 x 30 
minutes treadmill 
walking 
 
(supervised) 
Treadmill 
speed 
matched to 
lactate 
concentration 
of 3 mmol/L 
 
Correspondin
g to 80% 
APMHR or 
90% MHR 
Daily  
 
- ↑ maximum performance 
- ↑ Haemoglobin concentration 
- ↓ self-reported fatigue 
Hayes et al.21-24 .6 
(maximum) 
CCT Ex: 6 
C: 6 
M, W 16-64 
(range) 
Mixed 12 20-40 minutes treadmill 
walking or stationary 
cycling & 3-6 resistance 
machine exercises 
 
(supervised) 
 
70-90% MHR 3 aerobic 
sessions/wk 
 
2 resistance 
sessions/wk 
 
- ↑ VO2 & peak aerobic capacity 
- ↑ strength in upper body, lower body, & 
handgrip 
- ↑ global, physical and psychosocial QOL 
- ↔ immune parameters 
- ↑total energy expenditure 
- ↑fat-free mass with↓ in % body fat 
Thorsen et al.16 1 ±.25 
(mean & 
SD) 
RCT Ex: 59 
C: 52 
M, W 18-50 
(range) 
Mixed – 
mainly breast 
cancer (plus 
gynaecologic
al, lymphoma 
and testicular) 
14 At least 30min/ session 
Choice of exercise 
(usually walking, but 
also included cycling, 
strength training, water 
activities, ball games) 
 
(programme developed 
with exercise 
physiologist, but 
exercise was 
unsupervised) 
RPE 13-15 
 
Some patients 
used HR 
monitors: 60-
70% APHMR 
≥2 sessions/ 
wk  
 
- ↑ VO2 (predictedb) 
- ↔ mental distress and emotional 
function  
- greater ↓ in fatigue in control group 
 
N.B. mean number of days exercise was 
not different between exercise and control 
groups. Dose-response relationship 
identified in all patients between minutes 
exercise/ week and cardiovascular fitness 
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Hutnick et al.19 2 
(maximum) 
CCT Ex: 28 
C: 21 
W 29-71 
(range) 
Breast cancer 12 (total sessions = 40-90 
minutes) 
5 minute warm-up 
4 x upper and lower 
body resistance exercises 
(8-12 repetitions x 1-3 
sets) 
20 minutes aerobic 
treadmill exercise 
 
(supervised) 
Aerobic 
training: 60-
75% 
functional 
capacity 
(based on 
VO2 max) 
 
Resistance 
Training: Not 
reported 
3 sessions/ 
wk  
 
- ↑ VO2max 
- ↑ upper body strength 
- ↑ % of proliferating CD4+CD69+ T-
helper cells (immunologic indicators) 
- ↑ DNA synthesis 
- ↔ Plasma and mitogen-stimulated IL-6 
and IFN-γ production 
 
 
 
Nikander et 
al.17 
≤6 
(criteria) 
RCT Ex: 14 
C: 14 
W 41-65 
(range) 
Breast cancer 12 10 minute warm-up and 
cool-down 
30-40 minutes aerobic 
exercise (supervised: 
circuit based skipping 
and jumping, step-
aerobics/ unsupervised: 
walking, cycling, 
swimming etc) 
 
(Supervised and 
unsupervised) 
RPE 11-16 
 
(HR monitors 
were used to 
check 
intensity. 
Intended to be 
just below 
anaerobic 
threshold.) 
1 session/ 
wk 
supervised 
 
2-3 
sessions/ wk 
home-based 
unsupervise
d 
- ↑ physical performance (dynamic agility: 
figure-8 running test) 
- ↑ dynamic muscle performance (peak 
jumping power) 
- ↔ maximal isometric muscle force (leg 
extension & elbow flexion)  
- ↔ timed 2 km walk distance 
Allgayer et al.28 9 
(maximum) 
RT Moderate 
intensity 
Ex: 13 
 
Low 
Intensity 
Ex: 10 
M,W 49-60 
years 
(mean) 
Colorectal 
cancer 
2 30-40 minutes aerobic 
exercise (type not 
defined, stationary bike 
used for testing) 
 
(not reported but 
probably supervised 
since in hospital) 
30-40% or 
55-65% 
maximum 
power output 
depending on 
group. 
Daily 
individual 
exercise 
 
 
Moderate-intensity group vs. low-intensity 
group 
- ↓ anti-inflammatory response 
Allgayer et al.27 9 
(maximum) 
RT High 
intensity 
Ex: 29 
 
Moderate 
Intensity 
Ex: 19 
M,W 58-59 
years 
(mean) 
Colorectal 
cancer 
2 30-40 minutes aerobic 
exercise (type not 
defined, stationary bike 
used for testing) 
 
(not reported but 
probably supervised 
since in hospital) 
c 30-40% or 
50-60% 
maximum 
power output 
depending on 
group. 
Daily 
individual 
exercise 
 
Moderate Intensity Group: 
- ↓oxidative DNA damage (indicator of 
risk of recurrence) 
 
High Intensity Group: 
- ↑ DNA damage 
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Matthews et 
al.18 
≤12 
(criteria) 
[median = 
~10 
months) 
RCT Ex: 22 
C: 14 
W 51-57 
(mean) 
Breast cancer 12 20-40 minutes of 
walking 
 
[Home-based, 
unsupervised – + 1 x 30 
minute in-person 
counselling visit & 5 
brief phone calls over the 
12 weeks) ] 
RPE 11-13 3-5 walks/ 
wk 
 
- ↑ walking for exercise 
-  ↔ body composition/weight 
 
Hsieh et al.20 ‘within 
weeks of 
completing 
treatment’ 
(criteria) 
Pre-
test, 
Post-
test 
Ex: 74  
(n = 96 
but 22 
did not 
have 
adjuvant 
treatment, 
results 
from this 
group are 
not 
included  
here) 
W 57.9 ± 
10.4 
years 
(mean) 
Breast cancer ~26 60 minutes “whole-
body” exercise 
individually prescribed 
(e.g. 10 min warm-up, 
40 minutes aerobic/ 
resistance/ flexibility 
training, 10 minute cool-
down)  
 
Aerobic exercise 
included treadmill, 
stationary cycling, 
recumbent stepping, 
underwater treadmill. 
Resistance/ flexibility 
exercises targeted major 
muscle groups. 
 
(supervised) 
40-75% HRR 2-3 
individual 
sessions/ wk 
- ↑ predicted VO2 
- ↑ timed treadmill fitness test 
- ↑ % of age predicted forced vital 
capacity 
- ↓ resting HR 
- ↓ fatigue 
 RCT: randomised clinical controlled trial, CCT: controlled clinical trial (non-randomised), RT: Randomised Trial (comparing exercise groups of different intensities), Ex: exercise/intervention group, C: control group, 
HRR: heart rate reserve,  HDC: High-dose chemotherapy, PBST: peripheral blood stem-cell transplantation, ↔ no change, ↑ increase, ↓ decrease, ,APMHR: age predicted maximum heart rate (220 beats per minute - 
age), MHR: maximum heart rate (based on exercise testing), VO2: oxygen consumption (based on exercise testing), RPE: Borg’s Rating of Perceived Exertion scale (6-20), HR: Heart rate, wk: week, QoL: Quality of 
Life 
a The most accurate method reported for the study (maximum, mean & SD, or inclusion criteria) 
b ‘Predicted’ VO2 is determined using a submaximal exercise test and extrapolation. 
c Although given different names, the prescribed exercise in Allgayer28 and Allgayer27 was very similar. Low-intensity in Allgayer28 and moderate-intensity in Allgayer27 are defined as 30-40% of maximum power 
output. Moderate-intensity in Allgayer28 is defined as 55-65% and high-intensity in Allgayer27 is defined as 50-60% maximum power output. 
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Table 2. Methodological quality of studies that have evaluated the effects of exercise on cancer survivors during the rehabilitation period 
(sorted by ‘months since treatment’). 
Study Randomisation Unbiased 
randomisation 
process 
Blinding of data 
collectors 
Intention-to-treat 
analysis 
Adherence with exercise 
protocol 
Dimeo et 
al.26 
Yes NR NR No – 10 dropouts 
not included 
Participants completed 82% 
(±10%) of sessions 
Dimeo et 
al.25 
No – group allocation 
based on proximity to 
facility 
No NR No – 4 dropouts 
not included 
NR 
Hayes et 
al.21-24 
No – matched groups 
(age, gender, marriage 
status, exercise history, 
weight, living distance 
from centre, diagnosis, 
number of transplants, 
chemotherapy regime) 
NR NR No – 1 drop out 
not included  
67% of participants attended 
100% of sessions. 33% 
participants missed 1/12 
weeks. 
Thorsen et 
al.16 
Yes – stratified for sex & 
diagnosis 
Yes NR for fitness; 
No for 
Questionnaires 
(self-report) 
No – 28 drop outs 
not included. a 
 
97% of participants met the 
exercise frequency minimum 
of 2 sessions/week. 
N.B. 69% of control group 
participants also met this 
target. 
Hutnick et 
al.19 
No – group allocation 
based on geography 
and/or preference 
No NR Yes  82% of intervention 
participants attended all 
sessions in the first 3 months. 
Nikander 
et al.17 
Yes – stratified by age NR NR Yes Participants attended 78% of 
all supervised exercise 
sessions. 
Mean home sessions 
completed = 2.1 (meets study 
protocol) 
Matthews 
et al.18 
Yes – (2:1, intervention 
to control) 
NR NR – some 
outcomes were 
self-report 
Yes Participants completed 94% 
of the required number of 
walking sessions 
Allgayer 
et al.28 
No – based on week of 
treatment completion and 
some patients were 
allowed to switch to the 
alternate group after 
allocation 
NR NR – possibly 
since all 
outcomes were 
lab based 
Yes NR 
Allgayer 
et al.27 
No – based on week of 
treatment completion and 
some patients were 
allowed to switch to the 
alternate group after 
allocation 
NR NR – possibly 
since all 
outcomes were 
lab based 
No – 4 drop outs 
not included  
NR 
Hsieh et 
al.20 
Single group design NA NR NA ~90% adherence to exercise 
intervention (no further 
details were provided) 
 NR: not reported, NA: not applicable 
a Intention-to-treat analysis: “to some extent, ascertained that dropouts… had no significant effect on the results reported” 
 
 
